Biotechnology Index NYSE ETF (FBT)
$163.29 0.16 (0.10%)
19:59 EDT FBT Stock Quote Delayed 30 Minutes
Previous Close $163.29
Market Cap 1.92B
PE Ratio -
Volume (Avg. Vol.) 73,600
Day's Range 161.29 - 164.97
52-Week Range 108.08 - 167.61
Dividend & Yield N/A (N/A)
FBT Stock Predictions, Articles, and Biotechnology Index NYSE ETF News
- From InvestorPlace
- From the Web
Amid ongoing industry consolidation, attractive valuations and a strong broad market, catalysts are in place for more upside for biotech ETFs.
We have presented a bunch of top-performing ETFs of the nine-year bull market that will continue to outperform in the coming months. Compare Brokers...
These were the some of the best ETFs in January. Each outperformed the S&P 500 by at least 5% or more. Here's what investors need to know about each ETF.
While most of the sectors have flourished over the past decade, consumer discretionary and information technology have led the way .
After a painful 2016, biotech stocks are recovering this year. What lies ahead? Let's look at 5 biotech ETFs to find out
Among ETFs that hold biotech stocks, XBI looks like a winner, holding the advantages of equal-weighting and exposure to some potential highfliers.
The best ETFs in Q3 were sectors and countries rather than broader markets. Three ETFs from China, Middle East and biotech come to mind.